PMID- 37404257 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20230718 IS - 1178-6973 (Print) IS - 1178-6973 (Electronic) IS - 1178-6973 (Linking) VI - 16 DP - 2023 TI - Impact of Nosocomial Infection on in-Hospital Mortality Rate in Adult Patients Under Venoarterial Extracorporeal Membrane Oxygenation After Cardiac Surgery. PG - 4189-4200 LID - 10.2147/IDR.S390599 [doi] AB - OBJECTIVE: There was no consensus on the impact of nosocomial infection on In-hospital mortality rate in patients receiving ECMO. This study aimed to investigate the impact of nosocomial infection (NI) on In-hospital mortality rate in adult patients receiving venoarterial extracorporeal membrane oxygenation (VA-ECMO) after cardiac surgery. MATERIALS AND METHODS: This retrospective study included 503 adult patients who underwent VA-ECMO after cardiac surgery. The impact of time-dependent NIs on In-hospital mortality rate within 28 days of ECMO initiation was investigated using a Cox regression model. The cumulative incidence function for death was compared between patients with NIs and those without NIs using a competing risk model. RESULTS: Within 28 days after ECMO initiation, 206 (41.0%) patients developed NIs, and 220 (43.7%) patients died. The prevalence rates of NIs were 27.8% and 20.3% during and after ECMO therapy, respectively. The incidence rates of NIs during and after ECMO therapy were 49 per thousand and 25 per thousand, respectively. Time-dependent NI was an independent risk factor for predicting death (hazard ratio = 1.05, 95% confidence interval = 1.00-1.11). The cumulative incidence of death in patients with NI was significantly higher than that in patients without NI at each time point within 28 days of ECMO initiation. (Z = 5.816, P = 0.0159). CONCLUSION: NI was a common complication in adult patients who received VA-ECMO after cardiac surgery, and time-dependent NI was an independent risk factor for predicting mortality in these patients. Using a competing risk model, we confirmed that NIs increased the risk of In-hospital mortality rate in these patients. CI - (c) 2023 Li et al. FAU - Li, Xiyuan AU - Li X AD - Center for Cardiac Intensive Care, Beijing Institute of Heart, Lung, and Blood Vessel Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, People's Republic of China. AD - Department of Intensive Care Unit, Aviation General Hospital of China Medical University, Beijing, 100012, People's Republic of China. FAU - Wang, Xiaomeng AU - Wang X AD - Center for Cardiac Intensive Care, Beijing Institute of Heart, Lung, and Blood Vessel Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, People's Republic of China. FAU - Wang, Liangshan AU - Wang L AD - Center for Cardiac Intensive Care, Beijing Institute of Heart, Lung, and Blood Vessel Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, People's Republic of China. FAU - Li, Chenglong AU - Li C AD - Center for Cardiac Intensive Care, Beijing Institute of Heart, Lung, and Blood Vessel Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, People's Republic of China. FAU - Hao, Xing AU - Hao X AD - Center for Cardiac Intensive Care, Beijing Institute of Heart, Lung, and Blood Vessel Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, People's Republic of China. FAU - Du, Zhongtao AU - Du Z AD - Center for Cardiac Intensive Care, Beijing Institute of Heart, Lung, and Blood Vessel Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, People's Republic of China. FAU - Xie, Haixiu AU - Xie H AD - Center for Cardiac Intensive Care, Beijing Institute of Heart, Lung, and Blood Vessel Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, People's Republic of China. FAU - Yang, Feng AU - Yang F AD - Center for Cardiac Intensive Care, Beijing Institute of Heart, Lung, and Blood Vessel Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, People's Republic of China. FAU - Wang, Hong AU - Wang H AD - Center for Cardiac Intensive Care, Beijing Institute of Heart, Lung, and Blood Vessel Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, People's Republic of China. FAU - Hou, Xiaotong AU - Hou X AD - Center for Cardiac Intensive Care, Beijing Institute of Heart, Lung, and Blood Vessel Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, People's Republic of China. LA - eng PT - Journal Article DEP - 20230628 PL - New Zealand TA - Infect Drug Resist JT - Infection and drug resistance JID - 101550216 PMC - PMC10315138 OTO - NOTNLM OT - Cox regression OT - competing risk model OT - in-hospital mortality rate OT - nosocomial infection OT - venoarterial extracorporeal membrane oxygenation COIS- The authors report no conflicts of interest in this work. EDAT- 2023/07/05 13:05 MHDA- 2023/07/05 13:06 PMCR- 2023/06/28 CRDT- 2023/07/05 10:34 PHST- 2022/09/26 00:00 [received] PHST- 2023/05/30 00:00 [accepted] PHST- 2023/07/05 13:06 [medline] PHST- 2023/07/05 13:05 [pubmed] PHST- 2023/07/05 10:34 [entrez] PHST- 2023/06/28 00:00 [pmc-release] AID - 390599 [pii] AID - 10.2147/IDR.S390599 [doi] PST - epublish SO - Infect Drug Resist. 2023 Jun 28;16:4189-4200. doi: 10.2147/IDR.S390599. eCollection 2023.